Increasing Collaboration And Partnership For Microfluidics Technology Contributes to Market Growth

Microfluidics market was valued at $24,590 million in 2024 and is projected to reach $67,685 million by 2035, with a growing CAGR of 9.7% during the forecast period (2025-2035). Collaboration and strategic partnerships are playing a pivotal role in accelerating the development and commercialization of microfluidics technology. Various companies are implementing strategic partnerships through mergers and acquisitions, geographical expansion, and strategic collaborations to expand their market presence. As the field intersects multiple disciplines such as biology, chemistry, engineering, and information technology, collaborative efforts among companies, academic institutions, and research organizations are bringing innovative microfluidic solutions to the market. 

Browse the full report description of “Microfluidics Market Size, Share & Trends Analysis By Component (Microfluidic Chips, Micro Pumps, Microneedles, Microfluidic Actuators, Microvalves, Microchannels, Microwells, And Others), By Material (Polymer, Silicon, Glass, Other Materials), By Application (Lab-On-A-Chip, Organs-On-Chips, Continuous Flow Microfluidics, Optofluidics, Acoustofluidics, Electrophoresis) And Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/microfluidics-market

Collaboration and Partnership Moves 

• In March 2025, Microlight3D partnered with Eden Tech to deliver high-precision microfluidic design solutions for healthcare, diagnostics, and research applications. The collaboration combines Microlight3D’s Smart Print UV for producing any 2D shape at micron resolution, without a lithography mask, with Eden Tech’s FLUI’DEVICE platform, to create more rapid prototyping of microfluidic molds, devices, and structures, saving customers up to 90% in design time compared to traditional CAD tools.

• In December 2024, Dapu Biotechnology (DPBIO), an industry in droplet microfluidic technology, partnered with Leveragen, Inc., a Boston-based biotech developing advanced genetic models for antibody discovery, to accelerate innovations in antibody drug development. The collaboration brings together DPBIO’s Cytospark droplet microfluidic single-B cell antibody discovery platform and Leveragen’s Singularity Sapiens Mouse, a next-generation genetic model for fully human single-domain antibody development.

• In August 2024, Allozymes, a leading innovator in enzyme discovery and engineering, partnered with Adisseo, to develop bioprocesses for animal feed ingredient production. Unlike traditional methods that rely on slower protein engineering, Allozymes uses its proprietary microfluidics platform to develop custom enzymes with greater functionality in a fraction of the time. This innovative system designs, screens, and optimizes millions of enzyme candidates simultaneously, allowing a simple way to select the one with superior functionality.

• In February 2023, Amar Equipment launched 'NanoMake', India's first microfluidic platform for fast-track preclinical development of mRNA vaccines and nano-formulations, at the Institute of Chemical Technology's "Biosimilar Workshop". Microfluidic technologies have been employed to formulate nanomedicine with better controllable physical characteristics.

Key Players and Innovations

The major companies serving the Microfluidics market include Agilent Technologies, Inc., Danaher Corp., Bio-Rad Laboratories, Inc., Merck KGaA, Illumina, Inc., Thermo Fisher Scientific, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Component

o By Material

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Agilent Technologies, Inc., Danaher Corp., Bio-Rad Laboratories, Inc., Merck KGaA, Illumina, Inc., Thermo Fisher Scientific, Inc., and others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Microfluidics Market Report Segment

By Component

• Microfluidic Chips
• Micro Pumps
• Microneedles
• Other Components (Microfluidic Actuators, Microvalves, Microchannels, 
• Microwells, and other)

By Material

• Polymer
• Silicon
• Glass
• Other Materials 

By Application

• Lab-on-a-chip
• Organs-on-chips
• Continuous Flow Microfluidics 
• Optofluidics 
• Acoustofluidics 
• Electrophoresis 

Global Microfluidics Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/microfluidics-market